The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a...
Read moreIn addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political...
Read moreThe British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as...
Read moreAmarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the...
Read moreTeva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as...
Read moreAs many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years:...
Read moreAlnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver....
Read moreMerck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants...
Read moreRoche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a...
Read moreIt was a small study, with only 18 rectal cancer sufferers taking the same medicine. However, the outcomes were astounding....
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.